The drug stock is higher during the past month, while the S&P 500 has retired sharply.
Do not ignore the impact of pharmaceutical rates, says an analyst. Where we stop in Bristol Myers
You may also like...
The drug stock is higher during the past month, while the S&P 500 has retired sharply.